Mar 19, 2026 by Andy GouldIs Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.Relay Therapeutics develops precision oncology medicines using proprietary computational modeling and strategic industry partnerships.
Mar 19, 2026 by Andy GouldVNQI vs. REET: Which Global Real Estate ETF Is the Best Fit for Your Portfolio?Explore how key differences in holdings, risk, and regional focus set these two global real estate ETFs apart for investors.
Mar 18, 2026 by Andy GouldREET vs. RWX: Which Global Real Estate ETF Is the Better Buy?Compare how each ETF’s unique mix of holdings, costs, and market coverage could impact your real estate investing strategy.
Mar 18, 2026 by Andy GouldHAUZ vs. VNQ: Is This International Real Estate ETF a Better Buy for Income Investors?See how fee structures, yields, and global diversification distinguish these real estate ETFs for income-focused investors.
Mar 18, 2026 by Andy GouldVNQI vs. RWX: Which International Real Estate ETF Belongs in Your Portfolio?See how VNQI and RWX differ on fees, diversification, and portfolio focus -- all key factors for international real estate ETF investors.
Mar 18, 2026 by Andy GouldGQRE vs. VNQ: For These Real Estate ETFs, Is a Higher Yield Worth the Extra Cost?Explore how differing fees, global diversification, and liquidity shape the real estate ETF landscape for investors.
Mar 18, 2026 by Andy GouldRWR vs. ICF: Which REIT ETF Is the Better Buy for Income-Focused Investors?Explore how portfolio concentration and cost differences between these two REIT ETFs can impact your diversification and income strategy.
Mar 13, 2026 by Andy GouldIs Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector.
Mar 12, 2026 by Andy GouldKlaviyo Co-CEO Unloads $7 Million in Shares in February and March: Is This a Sell Signal?Klaviyo, a SaaS marketing automation leader, reported two notable insider sales in February and March.
Mar 12, 2026 by Andy GouldIWN vs. VBR: Which Small-Cap Value ETF Is the Better Buy?Explore how sector tilts, diversification, and cost differences set these two small-cap value ETFs apart for investors.
Jan 21, 2018 by Andy Gould2 Reasons to Buy Zoe’s Kitchen, 1 Reason to WaitThe fast-casual restaurant chain might be on the verge of a comeback.
Jan 21, 2018 by Andy GouldIs This Chain About to Buck the Restaurant Recession?For this full-service Tex-Mex chain, recent signs point to yes.
Jan 20, 2018 by Andy Gould3 Key Metrics for Duluth Holdings Investors to WatchWith most of the company’s growth tied to expanding retail sales, here are a few simple ways to measure its progress.
Jan 17, 2018 by Andy GouldWhat Investors Want to See From Zoe’s Kitchen in 2018After a terrible 2017, can the fast-casual Mediterranean chain bounce back?
Jan 16, 2018 by Andy Gould1 Dividend Stock to Buy and Hold for LifeStarbucks may no longer be the growth engine it once was, but it’s still a solid choice for investors in search of a stable business with attractive dividend prospects.
Jan 14, 2018 by Andy GouldHow Paycom Plans to Take Over the Payroll Software IndustryThese comments from management show how the payroll and HR software company plans to keep winning in 2018 and beyond.
Jan 12, 2018 by Andy GouldWhat Investors Want to See From TripAdvisor in 2018Two key improvements in the company’s struggling hotel business could help the online travel giant turn things around.
Jan 7, 2018 by Andy Gould2 Top Stocks to Start 2018These two tech companies are on a tear, stealing market share with plenty of room for growth.
Dec 27, 2017 by Andy GouldWorkday Management Ratchets Up Expectations for Its Financial PlatformDecelerating subscription revenue growth may lie ahead, but Workday is eyeing a sizeable opportunity with its financial management product.
Dec 24, 2017 by Andy GouldUp 75% in 2017, Here’s Why Paycom Software Had a Year to RememberAs well as the payroll and HR software company has performed, its long-term potential remains enormous.
